Literature DB >> 8473758

Fluconazole resistance in Candida in patients with AIDS--a therapeutic approach.

T T Ng1, D W Denning.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8473758     DOI: 10.1016/0163-4453(93)92707-4

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  18 in total

1.  Parity among the randomly amplified polymorphic DNA method, multilocus enzyme electrophoresis, and Southern blot hybridization with the moderately repetitive DNA probe Ca3 for fingerprinting Candida albicans.

Authors:  C Pujol; S Joly; S R Lockhart; S Noel; M Tibayrenc; D R Soll
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

2.  Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.

Authors:  Hua Quan; Ying-Ying Cao; Zheng Xu; Jing-Xia Zhao; Ping-Hui Gao; Xiao-Feng Qin; Yuan-Ying Jiang
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

Review 3.  Resistance of Candida species to fluconazole.

Authors:  J H Rex; M G Rinaldi; M A Pfaller
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

4.  Comparative resistance of Candida albicans clinical isolates to fluconazole and itraconazole in vitro and in vivo in a murine model.

Authors:  A Valentin; R Le Guennec; E Rodriguez; J Reynes; M Mallie; J M Bastide
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

Review 5.  Azole resistance in Candida.

Authors:  D W Denning; G G Baily; S V Hood
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-04       Impact factor: 3.267

6.  Genetic structure of Candida glabrata populations in AIDS and non-AIDS patients.

Authors:  T de Meeûs; F Renaud; E Mouveroux; J Reynes; G Galeazzi; M Mallié; J M Bastide
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

7.  Antagonism of azole activity against Candida albicans following induction of multidrug resistance genes by selected antimicrobial agents.

Authors:  K W Henry; M C Cruz; S K Katiyar; T D Edlind
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

Review 8.  Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans.

Authors:  P L Fidel; J A Vazquez; J D Sobel
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

9.  In vitro studies of a new antifungal triazole, D0870, against Candida albicans, Cryptococcus neoformans, and other pathogenic yeasts.

Authors:  T Peng; J N Galgiani
Journal:  Antimicrob Agents Chemother       Date:  1993-10       Impact factor: 5.191

10.  Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection.

Authors:  M Ruhnke; A Eigler; I Tennagen; B Geiseler; E Engelmann; M Trautmann
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.